Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

dc.contributor.authorCahn, Pedro
dc.contributor.authorFourie, Johan
dc.contributor.authorGrinsztejn, Beatriz
dc.contributor.authorHodder, Susan
dc.contributor.authorMolina, Jean-Michel
dc.contributor.authorRuxrungtham, Kiat
dc.contributor.authorWorkmang, Cassy
dc.contributor.authorVan De Casteele, Tom
dc.contributor.authorDe Doncker, Piet
dc.contributor.authorLathouwers, Erkki
dc.contributor.authorTomaka, Fred
dc.date.accessioned2024-05-23T18:53:33Z
dc.date.available2024-05-23T18:53:33Z
dc.date.issued2011
dc.description.abstractWeek 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients.
dc.identifier.citationCahn, P., Fourie, J., Grinsztejn, B., Hodder, S., Molina, J.-M., Ruxrungtham, K., ... Tomaka, F. (2011). Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients. AIDS.
dc.identifier.otherDOI: 10.1097/QAD.0b013e328345ee95
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/1102
dc.relation.ispartofseriesAIDS
dc.subjectDarunavir/ritonavir
dc.subjectTreatment-experienced
dc.subjectHIV-1-infected patients
dc.subjectOnce-daily vs. Twice-daily
dc.subjectWeek 48 analysis
dc.titleWeek 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

Files